Epstein Secrets

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

es Another Vaccine For Human Trials. EFTA00135745 The Wall Street Journal (9/30, Deng, Subscription Publication, 7.57M) reports Chinese drugmaker Shenzhen Kangtai, which is collaborating with AstraZeneca PLC on production of a coronavirus vaccine, has won approval from Chinese regulators to begin human testing

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

S China Approves Another Vaccine For Human Trials. The Wall Street Journal (9/30, Deng, Subscription Publication, 7.57M) reports Chinese drugmaker Shenzhen Kangtai, which is collaborating with AstraZeneca PLC on production of a coronavirus vaccine, has won approval from Chinese regulators to begin human testing

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

S China Approves Another Vaccine For Human Trials. The Wall Street Journal (9/30, Deng, Subscription Publication, 7.57M) reports Chinese drugmaker Shenzhen Kangtai, which is collaborating with AstraZeneca PLC on production of a coronavirus vaccine, has won approval from Chinese regulators to begin human testing